Arrowstreet Capital, Limited Partnership Xencor Inc Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $2.12 Million - $3.02 Million	113,722 New	113,722 $2.52 Million
Q3 2020 Nov 12, 2020	SELL	$30.09 - $43.02 $840,142 - $1.2 Million	-27,921 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$27.76 - $33.42 $775,086 - $933,119	27,921 New	27,921 $904,000
Q2 2018 Aug 14, 2018	SELL	$28.41 - $42.41 $597,121 - $891,373	-21,018 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$21.18 - $33.78 $445,161 - $709,988	21,018 New	21,018 $630,000

204

63.1M

3.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.21B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.